Cargando…
Encochleated Amphotericin B: Is the Oral Availability of Amphotericin B Finally Reached?
As the oldest and for many decades the only available agent for the treatment of life-threatening invasive fungal diseases, amphotericin B (AmB) is known for its broad-spectrum fungicidal activity against a wide range of yeasts and molds. However, the main drawback of the present formulations remain...
Autores principales: | Aigner, Maria, Lass-Flörl, Cornelia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7344640/ https://www.ncbi.nlm.nih.gov/pubmed/32443486 http://dx.doi.org/10.3390/jof6020066 |
Ejemplares similares
-
Efficacy of Oral Encochleated Amphotericin B in a Mouse Model of Cryptococcal Meningoencephalitis
por: Lu, R., et al.
Publicado: (2019) -
869. Oral Encochleated Amphotericin B for Cryptococcal Meningitis: a Phase II Randomized Trial
por: Atukunda, Mucunguzi, et al.
Publicado: (2022) -
Liposomal amphotericin B—the past
por: Brüggemann, R J, et al.
Publicado: (2022) -
LB1580. Efficacy Assessment of MAT2203 Encochleated Oral Formulation of Amphotericin B, in the Neutropenic Mouse Model of Pulmonary Mucormycosis
por: Gebremariam, Teclegiorgis, et al.
Publicado: (2022) -
Aspergillus terreus and the Interplay with Amphotericin B: from Resistance to Tolerance?
por: Vahedi-Shahandashti, Roya, et al.
Publicado: (2022)